Microarchitecture, Bone Strength and Fracture Risk in Long-term Type 1 Diabetes

NCT03751839 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2021-07-27

No results posted yet for this study

Summary

This single center case control study will assess differences in bone structure between women and men with longstanding type 1 diabetes (diabetes duration\>/= 25 years) and healthy controls.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DIAGNOSTIC_TEST

Biochemical Tests

The investigators will perform blood tests in every participant.

DIAGNOSTIC_TEST

Osteodensitometry

The investigators will perform an osteodensitometry in every participant.

DIAGNOSTIC_TEST

Clinical Tests

The investigators perform the following clinical tests: vibration threshold test, monofilament test, chair rise test and timed up and go test in every participant.

DIAGNOSTIC_TEST

HR-QCT

The investigators will perform HR-QCT measurements of the proximal femur and tibia in every participant.

DIAGNOSTIC_TEST

HR-pQCT

The investigators will perform HR-pQCT measurements of the distal radius and distal tibia in every participant.

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER
  • University Hospital Schleswig-Holstein

    collaborator OTHER
  • University Hospital, Basel, Switzerland

    collaborator OTHER
  • Christian Meier

    lead OTHER

Principal Investigators

  • Christian Meier, Prof. · University Hospital, Basel, Switzerland

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2021-07-01
Completion
2021-07-01

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03751839 on ClinicalTrials.gov